Desktop Genetics

About:

Desktop Genetics is a biotechnology company to helps researchers discover and treat the root genetic causes of human disease.

Website: http://www.desktopgenetics.com

Twitter/X: desktopgenetics

Top Investors: IQ Capital, UK Innovation & Science Seed Fund, Illumina Ventures, Angels in MedCity, Jonathan Milner

Description:

Desktop Genetics is an international biotechnology company to helps researchers discover and treat the root genetic causes of human disease. Desktop Genetics is a recognized leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians, and data scientists. The company's tools and technologies are used by organizations all over the world. It enables the work of their pharma, biotech, and academic customers working in drug discovery and functional genomics.

Total Funding Amount:

$8.47M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2012-01-01

Contact Email:

info(AT)deskgen.com

Founders:

Edward Perello, Riley Doyle, Victor Dillard

Number of Employees:

11-50

Last Funding Date:

2019-11-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai